+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Tinea pedis (Athlete Foot) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768211
  • Report
  • 71 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Biolab Farmaceutica Ltda
  • Maruho Co Ltd
  • Novartis AG
  • Pfizer Inc
  • Radiant Research Inc
  • York Pharma Plc
  • MORE
The global clinical trial report- “2019 Tinea pedis (Athlete Foot) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Tinea pedis (Athlete Foot). It presents in-depth analysis of Tinea pedis (Athlete Foot) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Tinea pedis (Athlete Foot).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Tinea pedis (Athlete Foot) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Tinea pedis (Athlete Foot)

The research work is prepared through extensive and continuous research on Tinea pedis (Athlete Foot) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Tinea pedis (Athlete Foot) patients are identified
  • The report includes panorama of Tinea pedis (Athlete Foot) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Tinea pedis (Athlete Foot) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biolab Farmaceutica Ltda
  • Maruho Co Ltd
  • Novartis AG
  • Pfizer Inc
  • Radiant Research Inc
  • York Pharma Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Tinea pedis (Athlete Foot) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Tinea pedis (Athlete Foot) Clinical Trials by Region
2.2.2 Average Enrollment of Tinea pedis (Athlete Foot) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Tinea pedis (Athlete Foot) Treatment, 2019

3. Region wise Tinea pedis (Athlete Foot) Clinical Trials
3.1 Asia Pacific Tinea pedis (Athlete Foot) Clinical Trials by Country
3.2 Europe Tinea pedis (Athlete Foot) Clinical Trials by Country
3.3 North America Tinea pedis (Athlete Foot) Clinical Trials by Country
3.4 Middle East and Africa Tinea pedis (Athlete Foot) Clinical Trials by Country
3.5 South and Central America Tinea pedis (Athlete Foot) Clinical Trials by Country

4. Tinea pedis (Athlete Foot) Clinical Trial Trends
4.1 Start Year wise Tinea pedis (Athlete Foot) Clinical Trials
4.2 Phase wise Tinea pedis (Athlete Foot) Clinical Trials
4.3 Trial Status wise Tinea pedis (Athlete Foot) Clinical Trials
4.4 Trial Type wise Tinea pedis (Athlete Foot) Clinical Trials

5. Tinea pedis (Athlete Foot) Average Enrollment Trends
5.1 Average Enrollment in Tinea pedis (Athlete Foot) Trials by Year
5.2 Average Enrollment in Tinea pedis (Athlete Foot) Trials by Phase
5.3 Average Enrollment in Tinea pedis (Athlete Foot) Trials by Status
5.4 Average Enrollment in Tinea pedis (Athlete Foot) Trials by Type of Trial

6. Companies Participating in Tinea pedis (Athlete Foot) Clinical Trials
6.1 Tinea pedis (Athlete Foot) Trials by Sponsor Type
6.2 Tinea pedis (Athlete Foot) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Tinea pedis (Athlete Foot) Trials- Phase 1
7.2 Tinea pedis (Athlete Foot) Trials- Phase 2
7.3 Tinea pedis (Athlete Foot) Trials- Phase 3
7.4 Tinea pedis (Athlete Foot) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Tinea pedis (Athlete Foot) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Figure 7: North America - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Figure 9: Tinea pedis (Athlete Foot) Clinical Trials by Phase
Figure 10: Tinea pedis (Athlete Foot) Clinical Trials by Trial Status
Figure 11: Tinea pedis (Athlete Foot) Clinical Trials by Type
Figure 12: Tinea pedis (Athlete Foot) Clinical Trials by Sponsor Type
Figure 13: Tinea pedis (Athlete Foot) Clinical Trials by Leading Sponsors
Figure 14: Tinea pedis (Athlete Foot) Average Enrollment by Phase
Figure 15: Tinea pedis (Athlete Foot) Average Enrollment by Trial Status
Figure 16: Tinea pedis (Athlete Foot) Average Enrollment by Type
Figure 17: Tinea pedis (Athlete Foot)- Average Enrolment by Type of Sponsors
Figure 18: Tinea pedis (Athlete Foot)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Tinea pedis (Athlete Foot) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Table 5: Europe - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Table 7: North America - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Tinea pedis (Athlete Foot) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Tinea pedis (Athlete Foot) Average Enrollment by Phase
Table 15: Tinea pedis (Athlete Foot) Average Enrollment by Trial Status
Table 16: Tinea pedis (Athlete Foot) Average Enrollment by Type
Table 17: Tinea pedis (Athlete Foot)- Average Enrolment by Type of Sponsors
Table 18: Tinea pedis (Athlete Foot)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AmDerma Pharmaceuticals LLC
  • Bausch Health Companies Inc
  • Biolab Farmaceutica Ltda
  • Maruho Co Ltd
  • Merz Pharma GmbH & Co KgaA
  • Novartis AG
  • Pfizer Inc
  • Radiant Research Inc
  • Sun Pharmaceutical Industries Ltd
  • York Pharma Plc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768211
Adroll
adroll